|
| ID |
DDInter474 |
| Drug Type |
small molecule |
| Molecular Formula |
C21H25Clo6 |
| Molecular Weight |
408.878
|
| Description |
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus.
|
| ATC Classification |
A10BK01
A10BD15
A10BD21
A10BD25
|
| IUPAC Name |
(2S,3R,4R,5S,6R)-2-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-6-(Hydroxymethyl)Oxane-3,4,5-Triol |
| InChI |
Inchi=1S/C21H25Clo6/C1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/H3-8,10,17-21,23-26H,2,9,11H2,1H3/T17-,18-,19+,20-,21+/M1/S1 |
| InChI Key |
JVHXJTBJCFBINQ-ADAARDCZSA-N |
| Canonical SMILES |
CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|